WhitTier Trust Company’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.8K | Hold |
11,200
| – | – | ﹤0.01% | 812 |
|
|
2025
Q1 | $35.6K | Hold |
11,200
| – | – | ﹤0.01% | 846 |
|
|
2024
Q4 | $59.9K | Hold |
11,200
| – | – | ﹤0.01% | 708 |
|
|
2024
Q3 | $59K | Hold |
11,200
| – | – | ﹤0.01% | 713 |
|
|
2024
Q2 | $20.3K | Hold |
11,200
| – | – | ﹤0.01% | 886 |
|
|
2024
Q1 | $19.8K | Hold |
11,200
| – | – | ﹤0.01% | 856 |
|
|
2023
Q4 | $19.6K | Hold |
11,200
| – | – | ﹤0.01% | 845 |
|
|
2023
Q3 | $16.4K | Buy |
11,200
+7,000
| +167% | +$10.2K | ﹤0.01% | 846 |
|
|
2023
Q2 | $9.58K | Hold |
4,200
| – | – | ﹤0.01% | 960 |
|
|
2023
Q1 | $3.82K | Hold |
4,200
| – | – | ﹤0.01% | 1039 |
|
|
2022
Q4 | $3.57K | Hold |
4,200
| – | – | ﹤0.01% | 1044 |
|
|
2022
Q3 | $3K | Hold |
4,200
| – | – | ﹤0.01% | 1006 |
|
|
2022
Q2 | $4K | Hold |
4,200
| – | – | ﹤0.01% | 1012 |
|
|
2022
Q1 | $7K | Hold |
4,200
| – | – | ﹤0.01% | 974 |
|
|
2021
Q4 | $10K | Hold |
4,200
| – | – | ﹤0.01% | 903 |
|
|
2021
Q3 | $20K | Hold |
4,200
| – | – | ﹤0.01% | 829 |
|
|
2021
Q2 | $11K | Hold |
4,200
| – | – | ﹤0.01% | 857 |
|
|
2021
Q1 | $13K | Hold |
4,200
| – | – | ﹤0.01% | 825 |
|
|
2020
Q4 | $15K | Hold |
4,200
| – | – | ﹤0.01% | 788 |
|
|
2020
Q3 | $17K | Buy |
+4,200
| New | +$17K | ﹤0.01% | 756 |
|